Post‐Endoscopic Retrograde Cholangiopancreatography Bleeding After Endoscopic Stone Removal in Dialysis Patients: A Multicenter Retrospective Study
DEN Open · 2027-04 · 7 (1)
DOI: 10.1002/deo2.70395 ↗Kurz gefasst
Fachartikel in der Zeitschrift DEN Open, online erschienen am 07.08.2026. Verfasst von Masaki Nishimura und 16 weiteren Autor:innen. Beteiligte Einrichtung: Gastroenterological Center Yokohama City University Medical Center Kanagawa Japan. Die Arbeit nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objectives
Post‐endoscopic retrograde cholangiopancreatography (post‐ERCP) bleeding occurs more frequently in dialysis patients than in non‐dialysis patients. This study aimed to identify risk factors for post‐ERCP bleeding following stone removal in patients undergoing dialysis.
Methods
This multicenter retrospective study enrolled 102 consecutive dialysis patients who underwent endoscopic stone removal at seven institutions between January 2009 and March 2022. Baseline characteristics, procedural details, stone removal outcomes, adverse events (AEs), and risk factors for post‐ERCP bleeding were analyzed.
Results
Of the 102 patients, 65 were men. Median patient age was 77 years (range, 51–91 years). Antithrombotic drugs were administered to 64 patients (63%). Endoscopic sphincterotomy, endoscopic papillary balloon dilation, and endoscopic papillary large balloon dilation were performed in 58 (57%), 20 (20%), and 11 (11%) patients, respectively. AEs occurred in 23 patients (23%), including bleeding in eight patients (8%), acute pancreatitis in nine patients (9%), cholangitis in seven patients (7%), and others in two patients (2%). Multivariate analysis identified intraoperative bleeding and continued aspirin use as independent risk factors for post‐ERCP bleeding. Similar associations were observed in subgroup analyses restricted to patients with a naïve papilla.
Conclusions
Intraoperative bleeding and continued aspirin use were associated with post‐ERCP bleeding following stone removal in dialysis patients, highlighting the importance of careful periprocedural hemostatic management in this population. Trial Registration Not applicable.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Gastroenterological Center Yokohama City University Medical Center Kanagawa Japan.
- Department of Gastroenterology Fujisawa City Hospital Kanagawa Japan.
- Department of Gastroenterology Yokohama City University Hospital Kanagawa Japan.
- Department of Gastroenterology Yokosuka City Hospital Kanagawa Japan.
- Department of Gastroenterology Japanese Red Cross Hadano Hospital Kanagawa Japan.
- Department of Gastroenterology Saiseikai Yokohamashi Nanbu Hospital Kanagawa Japan.
Zitieren
APA
Nishimura, M., Miwa, H., Kaneko, T., Kazuki, E., Ritsuko, O., Yuichi, S., Hiromi, T., Yoshimasa, S., Goda, Y., Funaoka, A., Doba, N., Irie, K., Miura, Y., Ishii, T., Kondo, M., Sugimori, K., & Maeda, S. (2027). Post‐Endoscopic Retrograde Cholangiopancreatography Bleeding After Endoscopic Stone Removal in Dialysis Patients: A Multicenter Retrospective Study. DEN Open, 7(1). https://doi.org/10.1002/deo2.70395
Vancouver
Nishimura M, Miwa H, Kaneko T, Kazuki E, Ritsuko O, Yuichi S, et al. Post‐Endoscopic Retrograde Cholangiopancreatography Bleeding After Endoscopic Stone Removal in Dialysis Patients: A Multicenter Retrospective Study. DEN Open. 2027;7(1). doi:10.1002/deo2.70395
BibTeX
@article{Nishimura2027,
author = {Nishimura, Masaki and Miwa, Haruo and Kaneko, Takashi and Kazuki, Endo and Ritsuko, Oishi and Yuichi, Suzuki and Hiromi, Tsuchiya and Yoshimasa, Suzuki and Goda, Yoshihiro and Funaoka, Akihiro and Doba, Nobutaka and Irie, Kuniyasu and Miura, Yuki and Ishii, Tomohiro and Kondo, Masaaki and Sugimori, Kazuya and Maeda, Shin},
title = {Post‐Endoscopic Retrograde Cholangiopancreatography Bleeding After Endoscopic Stone Removal in Dialysis Patients: A Multicenter Retrospective Study},
journal = {DEN Open},
year = {2027},
volume = {7},
number = {1},
doi = {10.1002/deo2.70395}
}
EUVIMED